Interview with Thomas Gardner, CEO of Biothech Company AtheraNova

Uploaded on Monday 26 March 2012

DESCRIPTION

AtheroNova (OTCBB: AHRO) is an early stage biotech company focused on discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits

DETAILS

Language: English

Length: 02:09

Country: United States

License:
Creative Commons License

Interview with Thomas Gardner, CEO of Biothech Company AtheraNova by bitLanders is licensed under a Creative Commons Attribution 3.0 License.


160